MAC vs OGN · rev $918.2M vs P/E 3.4, rev $6.40B
Macerich Company (MAC) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
Macerich Company (MAC) is a reit - retail company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported MAC revenue for 2024-12-31 was $918.2M. Net income was -$197.7M. Revenue was up 3.9% from 2023-12-31 to 2024-12-31. MAC currently screens at market cap $4.41B.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
MAC currently screens at market cap $4.41B. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the MAC and OGN stock pages for the full models.
Not investment advice.